---
title: "NHS National Generic Pharmaceuticals Wave 13"
ocid: "ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "ATAMIS LTD"
published: "2022-08-03"
---

# NHS National Generic Pharmaceuticals Wave 13

Buyer: ATAMIS LTD  
Current stage: Award  
OCID: ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be.json)

## Summary

The procurement process concerns the "NHS National Generic Pharmaceuticals Wave 13," facilitated by ATAMIS LTD based in Runcorn, UK. This open procurement, classified under pharmaceutical products, is currently in the award stage following its completion. The framework agreement has a duration of up to 28 months, with possibilities for extension extending to a total of 48 months. The effective contract period runs from 1 February 2022 to 31 May 2024. Key delivery regions include England and several associated territories such as Guernsey, Jersey, and the Isle of Man, with a total value of £469,741,550.

This tender presents substantial growth opportunities for businesses in the pharmaceutical sector, particularly those specialising in generic medications and related healthcare products. Small and medium enterprises (SMEs), especially those capable of fulfilling the diverse regional demands, are well-suited to compete. The open nature of the tender allows for a broad array of suppliers to engage, making it an attractive proposition for both established and emerging companies in the pharmaceutical market.

## Notice

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure (below threshold) |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Aug 2022 |
| Submission deadline | 26 Jul 2021 |
| Future notice date | Not specified |
| Award date | 30 Nov 2021 |
| Contract period | 1 Feb 2022 - 31 May 2024 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £469,741,550 |
| Lots value | Not specified |
| Awards value | £939,483,069 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | ATAMIS LTD |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 132 |
| Supplier names | ACCORD-UK; ACIUM; AGUETTANT; ALISSA HEALTHCARE RESEARCH; ALLERGAN; ALLIANCE PHARMACEUTICALS; ALTAN PHARMA; ALTURIX; AMAROX; AOP ORPHAN; ARCADIA PHARMA LTD T/A ARCADIA MEDICAL; ARISTO PHARMA; ASCEND LABORATORIES; ASPEN PHARMACARE; ASPIRE PHARMA; ATNAHS PHARMA; AVENTIS PHARMA LTD T/A SANOFI; B. BRAUN MEDICAL; BAXTER HEALTHCARE; BAYER; BEAUMONT PHARMA; BOWMED IBISQUS; BRISTOL LABORATORIES; BROWN & BURK; CHIESI; CIPLA (EU; CLYDESDALE PHARMA; COLONIS PHARMA; CONSILIENT HEALTH; CORREVIO; CRESCENT PHARMA; CST PHARMA; DAY LEWIS MEDICAL; DERMA; DESITIN PHARMA; DEXCEL PHARMA; DR FALK PHARMA; DR.REDDY'S LABORATORIES (UK; DRUGSRUS; ENNOGEN HEALTHCARE; EURO-LINK PHARMA; FERNDALE PHARMACEUTICALS; FERRING PHARMACEUTICALS; FLEXIPHARM AUSTRADING; FLYNN PHARMA; FOCUS PHARMACEUTICALS; FONTUS HEALTH; FRESENIUS KABI; GALEN; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMA; HEALTHCARE PHARMA; INTRAPHARM LABORATORIES; IPCA LABORATORIES; KENSINGTON PHARMA; KENT PHARMA; KYOWA KIRIN; LABORATORIO REIG JOFRE; LEO PHARMA; LOGIXX PHARMA; LUCANE PHARMA; LUNDBECK; LUPIN HEALTHCARE (UK; MACLEODS PHARMA; MACURE PHARMA; MANX HEALTHCARE; MARTINDALE PHARMA; MEDAC PHARMA; MEDLEY PHARMA; MEDREICH; MERCK SHARPE & DOHME (UK; MERCURY PHARMACEUTICALS; MIBE PHARMA; MILPHARM LTD/AUROBINBDO; MIP PHARMA; MORNINGSIDE PHARMAEUTICALS; MYLAN; NAPP PHARMACEUTICALS; NECESSITY SUPPLIES; NEON HEALTHCARE; NEXCAPE PHARMACEUTICALS; NORGINE PHARMACEUTICALS; NORTHUMBRIA PHARMA; NOUMED LIFE SCIENCES; ORALIEVE; ORGANON PHARMACEUTICALS; P M PHARMA; PANPHARMA; PARI; PFIZER; PHOENIX LAB; PIERRE FABRE; PROFILE PHARMA; RANBAXY; RECKITT BENCKISER; RECORDATI PHARMACEUTICALS; RECORDATI RARE DISEASES; RELONCHEM; RIVOPHARM; ROCHE PRODUCTS; ROMA PHARMACEUTICALS; ROSEMONT PHARMACEUTICALS; RPH PHARMACEUTICALS; SANDOZ; SCIECURE PHARMA; SEACROSS PHARMACEUTICALS; SELECTIVE SUPPLIES; SINTETICA; SOBI (SWEDISH ORPHAN BIOVITRUM; STRAGEN; STRIDES PHARMA; SYNCHRONY; SYRI LIMITED (T/A THAME LABORATORIES; TAKEDA; TETRIS PHARMA; TEVA; THEA PHARMACEUTICALS; THORNTON AND ROSS; TILLOMED LABORATORIES; TORBAY PHARMACEUTICALS; TORRENT PHARMA; TRANSDERMAL; TYPHARM; UPJOHN; V PHARMA; VANTAGE PHARMACEUTICALS; WAVERLEY PHARMA EUROPE; WAYMADE; WOCKHARDT; ZENTIVA PHARMA; ZISTA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 3 Aug 2022 at 07:38 - AwardUpdate - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb
- 3 Aug 2022 at 07:35 - AwardUpdate - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb
- 27 Jul 2022 at 11:35 - AwardUpdate - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb
- 22 Jul 2022 at 14:53 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb
- 20 Jan 2022 at 12:23 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/7a21e098-6036-4e9f-8b7f-6f99c067cc68

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb
  3rd August 2022 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/7a21e098-6036-4e9f-8b7f-6f99c067cc68
  20th January 2022 - Awarded contract notice on Contracts Finder
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000H9vt/9if0EfI0R_ePtymInJf8519NEBxssPYQEpXrolEIb8Y
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000H9vx/PVQEZp96LPD0S8__28UZV4kPcNKjALeURw2Q9XLyS24
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000H9vs/ucdPCyBQJ6kKVtBs8Rm_sMX0QLPAtSNAmYa8b8HGxPQ
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000J5ri/JgZFLSdoeL2WF4Nwq4iK4nhjezPe5aIvK6cfPzUyZsg

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be.json.